Key facts
- This page summarizes Braden M. Leonard's Form 4 filing for Aclaris Therapeutics, Inc. (ACRS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2024, 15:57.
Braden M. Leonard - 02 Aug 2024 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ACRS
- Reported as of
- 02 Aug 2024
- Net transaction value
- +$472,757
- SEC form
- 4
- Accepted by SEC
- 05 Aug 2024, 15:57:34 UTC
- Prior SEC filing
- 31 Jul 2024
- Next SEC filing
- 12 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- Braden Michael Leonard
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Braden M. Leonard filed Form 4 for Aclaris Therapeutics, Inc. (ACRS) on 05 Aug 2024.
Change
- Previous filing in this sequence was filed on 31 Jul 2024.
- Current net transaction value: +$472,757.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACRS
transaction
Common Stock
Purchase
- Transaction value
- $216,400
- Shares
- +167,544
- Change %
- +1.2%
- Price
- $1.29
- Shares after
- 14,043,975
- Date
- 02 Aug 2024
- Ownership
- Holding of BML Investment Partners, L.P.
- Footnotes
- F1, F2
ACRS
transaction
Common Stock
Purchase
- Transaction value
- $256,357
- Shares
- +206,025
- Change %
- +1.5%
- Price
- $1.24
- Shares after
- 14,250,000
- Date
- 05 Aug 2024
- Ownership
- Holding of BML Investment Partners, L.P
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Footnote F2
Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.2916 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
Footnote F3
Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.2443 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.